journal
MENU ▼
Read by QxMD icon Read
search

Journal of Clinical Psychopharmacology

journal
https://www.readbyqxmd.com/read/28719424/excessive-and-frequent-menstrual-bleeding-with-methylphenidate-in-an-adolescent-girl-with-attention-deficit-hyperactivity-disorder
#1
Murat Coskun, Ibrahim Adak
No abstract text is available yet for this article.
July 17, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28719423/sleepwalking-is-associated-with-coadministration-of-olanzapine-and-propranolol-a-case-report
#2
Shuhua Deng, Jinqing Hu, Xiuqing Zhu, Dewei Shang, Yuguan Wen, Chang Qiu
No abstract text is available yet for this article.
July 17, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28708736/mifepristone-plasma-level-and-glucocorticoid-receptor-antagonism-associated-with-response-in-patients-with-psychotic-depression
#3
Thaddeus Block, Georgios Petrides, Harvey Kushner, Ned Kalin, Joseph Belanoff, Alan Schatzberg
BACKGROUND: Psychotic depression has no Food and Drug Administration-approved treatment. Patients demonstrate significant dysregulation of the hypothalamic-pituitary-adrenal axis providing a biologically targeted treatment opportunity. The purpose of this study was to explore the clinical and biological effects of short-duration (7-day) glucocorticoid receptor antagonism with mifepristone and the role of mifepristone plasma levels in patients with psychotic depression. METHODS: This double-blind, randomized study took place at 34 US clinical research centers and included patients with a diagnosis of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, major depressive disorder, severe, with psychotic features...
July 13, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28650930/clozapine-use-in-a-cohort-of-first-episode-psychosis
#4
Roisin Doyle, Caragh Behan, Donal OʼKeeffe, Sarah Masterson, Anthony Kinsella, Aine Kelly, Ann Sheridan, Dolores Keating, Caroline Hynes, Kevin Madigan, Elizabeth Lawlor, Mary Clarke
PURPOSE/BACKGROUND: For approximately one third of individuals treated for psychosis or schizophrenia, antipsychotic medications will have little or no therapeutic benefit. Clozapine remains the sole medication approved for treatment-resistant schizophrenia, and studies have demonstrated its superior efficacy in reducing psychotic symptoms. METHODS/PROCEDURES: Data were collected from the medical records of people who originally presented with a first-episode psychosis between 1995 and 1999 (N = 171)...
June 23, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28640071/worsening-of-myasthenia-gravis-after-administration-of-antipsychotics-for-treatment-of-schizophrenia-a-case-report-and-review-of-literature
#5
Shenglin She, Wenying Yi, Bei Zhang, Yingjun Zheng
No abstract text is available yet for this article.
June 20, 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28622162/salute-to-our-reviewers
#6
Barbara Kern
No abstract text is available yet for this article.
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28622161/antipsychotic-use-among-adult-outpatients-and-venous-thromboembolic-disease-a-retrospective-cohort-study
#7
Augusto Ferraris, Alejandro G Szmulewicz, Fernando J Vazquez, William M Vollmer, Federico Angriman
BACKGROUND: Treatment with antipsychotic (AP) agents is associated with incident thromboembolic events. However, the underpinnings of this association remain unknown. We sought to evaluate the effect of AP agents-categorized by their metabolic/sedative and hyperprolactinemia adverse effect profile-on the risk of venous thromboembolic disease during long-term follow-up. METHODS: A retrospective cohort study of adult patients initiating AP treatment for the first time was conducted...
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28614160/delusional-pregnancy-presenting-to-the-massachusetts-general-hospital-national-pregnancy-registry-for-atypical-antipsychotics
#8
Alexandra Z Sosinsky, Marlene P Freeman, Gina M Savella, Laura J Cheng, Adele C Viguera, Lee S Cohen
No abstract text is available yet for this article.
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28614159/dissociative-intoxication-and-prolonged-withdrawal-associated-with-phenibut-a-case-report
#9
Yash B Joshi, Samantha F Friend, Berenice Jimenez, Louisa R Steiger
No abstract text is available yet for this article.
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28609307/a-6-year-posttreatment-follow-up-of-panic-disorder-patients-treatment-with-clonazepam-predicts-lower-recurrence-than-treatment-with-paroxetine
#10
Rafael C Freire, Roman Amrein, Marina D Mochcovitch, Gisele P Dias, Sergio Machado, Marcio Versiani, Oscar Arias-Carrión, Mauro G Carta, Antonio E Nardi
BACKGROUND: The aim of this study was to identify factors associated with relapse in panic disorder (PD). METHODS: This was an observational study conducted in the outpatient clinic of a psychiatric hospital in Rio de Janeiro, Brazil. In a previous study, 120 patients diagnosed as having PD according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria were randomized to receive clonazepam or paroxetine. After 3 years, treatment was discontinued in patients who had achieved remission...
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28609306/the-impact-non-factor
#11
David J Greenblatt, Richard I Shader
No abstract text is available yet for this article.
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28609305/phenelzine-withdrawal-associated-psychosis-and-mania
#12
Wanda Shao, Tanida Brown, Shehzad Ayub
No abstract text is available yet for this article.
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28604421/propranolol-treatment-of-cannabinoid-hyperemesis-syndrome-a-case-report
#13
John R Richards, Oliver Dutczak
No abstract text is available yet for this article.
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28591067/bergamot-polyphenolic-fraction-supplementation-improves-cognitive-functioning-in-schizophrenia-data-from-an-8-week-open-label-pilot-study
#14
Antonio Bruno, Gianluca Pandolfo, Manuela Crucitti, Clemente Cedro, Rocco Antonio Zoccali, Maria Rosaria Anna Muscatello
BACKGROUND: Novel treatment strategies for cognitive dysfunctions may prevent long-term disability in patients with schizophrenia, and polyphenolic compounds might be a promising strategy. Bergamot (Citrus bergamia), a citrus fruit characterized by a high amount of flavonoids and flavonoid glycosides, may represent a potential nutraceutical approach to cognitive dysfunction. The present study was aimed to explore the efficacy of bergamot polyphenolic fraction (BPF) supplementation on cognitive/executive functioning in a sample of patients with schizophrenia receiving second-generation antipsychotics...
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28590372/changes-in-neutrophil-count-after-antipsychotic-prescription-among-a-retrospective-cohort-of-patients-with-benign-neutropenia
#15
Paul Campion, Gabriel Campion, Deepti Anbarasan
BACKGROUND: There is a paucity of literature regarding the effect of antipsychotics on absolute neutrophil count (ANC) of patients with benign neutropenia (BN). We evaluated the change in ANC after atypical antipsychotic prescription (excluding clozapine) in a retrospective cohort of 22 patients with BN. METHODS/PROCEDURES: Records of all patients with BN who were prescribed antipsychotics and who had ANC measured before and during antipsychotic treatment were obtained from Bronx VA Medical Center between 2005 and 2015 (inclusive)...
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28590371/cocaine-abuse-traumatic-brain-injury-and-preexisting-brain-lesions-as-risk-factors-for-bupropion-associated-psychosis
#16
Rajdip Barman, Sanjeev Kumar, Bhuvaneshwar Pagadala, Mark B Detweiler
BACKGROUND AND OBJECTIVE: Bupropion is generally considered safe and is widely used both as a monotherapy and as an augmentation agent for the treatment of major depression. Concerns have been raised about bupropion's propensity to precipitate new psychosis and worsen existing psychotic symptoms, although the mechanism is poorly understood. Three cases are reported in which bupropion use was associated with psychosis. The aim of the study was to explore the risk factors and possible mechanisms of psychosis in each case...
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28590370/early-improvement-predicts-treatment-outcomes-for-patients-with-acute-mania-a-naturalistic-study-in-taiwan
#17
Dian-Jeng Li, Ching-Hua Lin, Mei-Jou Lu
BACKGROUND: Bipolar disorder is a serious mental disorder. This study investigated whether early improvement at week 1 or 2 could predict treatment outcomes at week 4 in clinical populations with acute mania. METHODS: We conducted a naturalistic study, recruiting inpatients with bipolar mania for acute treatment. Symptom severity was assessed using the Young Mania Rating Scale (YMRS) at weeks 0, 1, 2, 3, and 4. Early improvement was defined as a reduction in the YMRS score of at least 20% or 25%, assessed at weeks 1 and 2...
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28590369/adverse-events-with-sustained-release-donepezil-in-alzheimer-disease-relation-to-body-mass-index
#18
Chunsoo Lee, Kyungsang Lee, Hyewon Yu, Seung-Ho Ryu, Seok Woo Moon, Changsu Han, Jun-Young Lee, Young Min Lee, Shin-Gyeom Kim, Ki Woong Kim, Dong Woo Lee, Seong Yoon Kim, Sang-Yeol Lee, Jae Nam Bae, Young-Eun Jung, Jeong Lan Kim, Byung-Soo Kim, Il-Seon Shin, Young Hoon Kim, Bong Jo Kim, Hyo Shin Kang, Woojae Myung, Bernard J Carroll, Doh Kwan Kim
PURPOSE/BACKGROUND: Sustained-release, high-dose (23 mg/d) donepezil has been approved for treatment of moderate to severe Alzheimer disease (AD). Based on a previous clinical trial, body weight of less than 55 kg is a risk factor for adverse events with donepezil 23 mg/d treatment in global population. METHODS/PROCEDURES: To clarify whether this finding is consistent across ethnic groups that vary in absolute body mass, we recruited Korean patients aged 45 to 90 years with moderate to severe AD who had been receiving standard donepezil immediate release 10 mg/d for at least 3 months...
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28590368/priapism-associated-with-antipsychotic-medication-use-case-report
#19
Emily Fu, Jessica G Kovach, William R Dubin
No abstract text is available yet for this article.
August 2017: Journal of Clinical Psychopharmacology
https://www.readbyqxmd.com/read/28590367/statistics-commentary-series-commentary-no-21-using-diagnostic-tests-or-the-search-for-universal-truths
#20
David L Streiner
No abstract text is available yet for this article.
August 2017: Journal of Clinical Psychopharmacology
journal
journal
28217
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"